Literature DB >> 29402144

Mitochondrial Ferritin Is a Hypoxia-Inducible Factor 1α-Inducible Gene That Protects from Hypoxia-Induced Cell Death in Brain.

Qiong Wu1,2,3,4, Wen-Shuang Wu1,3,4, Lin Su1, Xin Zheng1, Wen-Yue Wu1, Paolo Santambrogio2, Yu-Jing Gou1, Qian Hao1, Pei-Na Wang1, Ya-Ru Li1, Bao-Lu Zhao1, Guangjun Nie5, Sonia Levi2,6, Yan-Zhong Chang1.   

Abstract

Aims: Mitochondrial ferritin (protein [FtMt]) is preferentially expressed in cell types of high metabolic activity and oxygen consumption, which is consistent with its role of sequestering iron and preventing oxygen-derived redox damage. As of yet, the mechanisms of FtMt regulation and the protection FtMt affords remain largely unknown.
Results: Here, we report that hypoxia-inducible factor 1α (HIF-1α) can upregulate FtMt expression. We verify one functional hypoxia-response element (HRE) in the positive regulatory region and two HREs possessing HIF-1α binding activity in the minimal promoter region of the human FTMT gene. We also demonstrate that FtMt can alleviate hypoxia-induced brain cell death by sequestering uncommitted iron, whose levels increase with hypoxia in these cells. Innovation: In the absence of FtMt, this catalytic metal excess catalyzes the production of cytotoxic reactive oxygen species.
Conclusion: Thus, the cell ability to increase expression of FtMt during hypoxia may be a skill to avoid tissue damage derived from oxygen limitation.

Entities:  

Keywords:  HIF-1α; ROS; hypoxia-induced apoptosis; mitochondrial ferritin

Mesh:

Substances:

Year:  2018        PMID: 29402144     DOI: 10.1089/ars.2017.7063

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  5 in total

1.  Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibiting ferroptosis.

Authors:  Peina Wang; Yanmei Cui; Qianqian Ren; Bingqi Yan; Yashuo Zhao; Peng Yu; Guofen Gao; Honglian Shi; Shiyang Chang; Yan-Zhong Chang
Journal:  Cell Death Dis       Date:  2021-05-05       Impact factor: 8.469

Review 2.  Nanomedicine targets iron metabolism for cancer therapy.

Authors:  Liangru Lin; Hanqing Chen; Ruifang Zhao; Motao Zhu; Guangjun Nie
Journal:  Cancer Sci       Date:  2022-02-07       Impact factor: 6.716

Review 3.  Therapeutic targeting of mitophagy in Parkinson's disease.

Authors:  Shashank Masaldan; Sylvie Callegari; Grant Dewson
Journal:  Biochem Soc Trans       Date:  2022-04-29       Impact factor: 4.919

4.  Overexpression of Mitochondrial Ferritin Enhances Blood-Brain Barrier Integrity Following Ischemic Stroke in Mice by Maintaining Iron Homeostasis in Endothelial Cells.

Authors:  Peina Wang; Qianqian Ren; Mengtong Shi; Yuanyuan Liu; Huiyuan Bai; Yan-Zhong Chang
Journal:  Antioxidants (Basel)       Date:  2022-06-26

Review 5.  Biochemistry of mammalian ferritins in the regulation of cellular iron homeostasis and oxidative responses.

Authors:  Jianlin Zhang; Xuehui Chen; Juanji Hong; Aifa Tang; Yang Liu; Ni Xie; Guohui Nie; Xiyun Yan; Minmin Liang
Journal:  Sci China Life Sci       Date:  2020-09-17       Impact factor: 6.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.